Targeting the DNA Damage Response in Cancer
ABSTRACT The DNA damage response (DDR) is increasingly recognized not only as a genome‐maintenance network and source of synthetic‐lethal vulnerabilities, but also as a regulator of tumor immunity. DDR defects and pharmacologic inhibition can increase neoantigen formation, generate micronuclei and cytosolic nucleic aci...